Health Case Studies
AbRegen and Ferronova
AbRegen is a preclinical stage biotechnology company that specialises in the development of antibody-based
therapeutics for tissue repair applications.
Ferronova is a cancer diagnostics company, developing magnetic probe and tracer systems for improved lymph node identification.
Tech Flyers
14-3-3 Cancer Therapeutics
A novel class of 14-3-3 targeting anti-cancer drugs.
Advancing Prognostic Tests for Multiuple Myeloma
A novel biomarker based test for better prognosis of patients with multiple myeloma.
Australian Bush Bioactives
Australian Indigenous native plant bioactive extracts and compounds with potent non-steroidal anti-inflammatory activity.
Assay Ready Plates
Off the shelf solution for drug response testing.
Foroderm
Painless, low cost and safe bioactive delivery system.
Inulin-Lipid Hybrid (ILH) Technology
Dry powder formulation that affords high drug and lipid stability through the micro-encapsulation approach.
Liquid Crystal Nanoparticles (LCNP) Enhances Antimicrobial Efficiency
Novel formulation approach that direct antibiotics into biofilm (chronic) infections, enhancing the efficacy of cationic antimicrobials by at least 100-fold against biofilm bacterial infections.
MYB Inhibitors
In development for treatment of Acute Myeloid Leukaemia (AML) and other Cancers.
Polymer-lipid Hybrid (PLH) Microparticles
A novel hybrid drug delivery formulation that can be used in a wide range of therapeutic applications.
Ultra Low Attachment (ULA) Coatings
Adaptable surface coating to deter cells from attaching.
Variant Grid
A graphical user interface that allows non-experts to filter, search and analyse a patient’s genetic variants in a database.
